Venus Concept Inc (VERO): Kapitalisasi marang pendapatan
Venus Concept Inc. (VERO) develops advanced non-invasive rejuvenation systems, making aesthetic correction accessible. Business restructuring and the sale of consumables in the US drive growth. The brand is recognized as a reliable global supplier of high-quality equipment. The current price-to-sales ratio helps assess market balance, while 0.00 reflects the latest metric level on this chart.
Rincian analitis perusahaan Venus Concept Corp (VERO)
- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi bursa:
- indikator nilai buku ekuitas:
- statistik kawajiban utang lan likuiditas:
Koefisien Total Utang marang Modal Venus Concept Inc.|VERO - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Venus Concept Corporation|VERO - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Venus Concept Corp|VERO - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Venus Concept|Rasio jangkoan perantara venusconcept.com
- data bathi lan kelipatan valuasi:
VERO - Bathi resik|Bathi resik sing dikarepake Venus Concept Inc.|VERO - Rasio rega marang bathi|Pangali forward rega marang bathi Venus Concept Inc|VERO - Pangali rega marang bathi tumrap wutah|Pangali EV/EBITDA Venus Concept Corp|VERO - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan Venus Concept|VERO - Bathi saben saham sajrone rolas wulan pungkasan|Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan venusconcept.com|VERO - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Venus Concept Inc.
- rincian pendapatan lan dodolan emiten:
Analisis umum perusahaan:VERO venusconcept.com
The efficiency of Venus Concept Inc. (VERO) Canadian production facilities for aesthetic equipment is reflected in the price-to-sales ratio, which compares market capitalization to annual revenue. This metric, calculated by dividing the total equity value by revenue, allows investors to assess the degree of overpayment for the business and the risk of correction at inflated values or the asset's undervaluation.
Pesaing Venus Concept Inc.
DXCM (dexcom.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Penumbra PEN|NOVT - Kapitalisasi marang pendapatan|Haemonetics Corp. - Multiplikator P/S|Rega marang dodolan Inspire Medical Systems Inc|PRCT: Multiplikator P/S|Rasio kapitalisasi marang pendapatan CNMD|PLSE (Pulse Biosciences) - Multiplikator P/S|InMode Ltd (INMD) - Koefisien rega marang pendapatan|Multiplikator P/S PMI|Kapitalisasi marang pendapatan Surmodics Inc. SRDX|Multiplikator P/S SENS (Senseonics Holdings)|Multiplikator P/S neuropace.com NPCE|TCMD - Rasio rega marang pendapatan|SNWV: Rasio rega marang pendapatan|OM (Outset) - Kapitalisasi marang pendapatan|Electromed - Rasio kapitalisasi pasar marang pendapatan|LNSR (LENSAR, Inc.) - Multiplikator P/S|Rega marang dodolan avitamedical.com RCEL|Rasio rega marang pendapatan Profound Medical Corp. (PROF)|bairdmed.com (BDMD) - Multiplikator rega marang pendapatan|EDAP TMS - Kapitalisasi marang pendapatan|Multiplikator P/S Apyx Medical Corp APYX|IceCure Medical, Ltd. - Multiplikator P/S|Koefisien rega marang pendapatan Pulmonx Corporation LUNG|telabio.com (TELA) - Rasio rega marang pendapatan|Rasio rega marang dodolan CTSO (CytoSorbents Corporation)|Rasio rega marang pendapatan Sensus Healthcare Corp|Kapitalisasi marang pendapatan Zynex Corp (ZYXI)|Multiplikator P/S ECOR|RBOT - Rega marang dodolan|Rasio rega marang pendapatan Inspira Technologies IINN|ICU: Rasio kapitalisasi marang pendapatan|IRIX: Kapitalisasi marang pendapatan|Intelligent Bio Solutions - Kapitalisasi marang volume dodolan|XAIR (beyondair.net) - Kapitalisasi marang pendapatan|PFSA (profusa.com) - Rasio rega marang pendapatan|SSKN (STRATA Skin Sciences Inc.) - Multiplikator P/S|Rega marang dodolan glucotrack.com GCTK|Rasio rega marang pendapatan NanoVibronix (NAOV)|Nuwellis Corp - Rasio kapitalisasi marang pendapatan|Aethlon Medical - Kapitalisasi marang pendapatan|Multiplikator P/S Asensus Surgical Inc ASXC|AVGR - Rasio rega marang pendapatan|Koefisien rega marang pendapatan BioSig BSGM|CUTR (Cutera, Inc) - Kapitalisasi marang pendapatan|Know Labs Corporation - Rasio kapitalisasi pasar marang pendapatan|NARI (Inari Medical, Inc.) - Multiplikator P/S|Kapitalisasi marang pendapatan nevro.com (NVRO)|Rasio rega marang pendapatan ReShape Lifesciences (RSLS)|SILK - Rega marang dodolan
